NCT01255956View on ClinicalTrials.gov

Restenosis Treatment With Rapamycin Eluting Stent or Paclitaxel Eluting Balloon Catheter (RESTENOZA)

PHASE3UnknownINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
In-Stent Restenosis
Interventions
DEVICE

Rapamycin eluting stent implantation

Rapamycin eluting stent implantation for in-stent restenosis treatment

DEVICE

Paclitaxel eluting balloon catheter

Paclitaxel eluting balloon catheter for in-stent restenosis treatment

Trial Locations (4)

04-628

RECRUITING

Instytut Kardiologii w Warszawie-Aninie, Warsaw

02-097

RECRUITING

Katedra i Klinika Kardiologii Warszawskiego Uniwersytetu Medycznego, Warsaw

91-347

RECRUITING

Klinika Kardiologii z Kliniką Kardiochirurgii Uniwersyteckiego Szpitala Klinicznego w Lodzi, Lodz

31-500

RECRUITING

II Department of Cardiology Medical College Jagiellonian University University Hospital in Krakow, Krakow

Sponsors

Collaborators (1)

KCRI
All Listed Sponsors
collaborator

KCRI

OTHER

lead

Medical University of Warsaw

OTHER

NCT01255956 - Restenosis Treatment With Rapamycin Eluting Stent or Paclitaxel Eluting Balloon Catheter (RESTENOZA) | Biotech Hunter | Biotech Hunter